Cross-species immunity in malaria vaccine development: two, three, or even four for the price of one?
作者信息
Douradinha Bruno, Mota Maria M, Luty Adrian J F, Sauerwein Robert W
机构信息
Department of Medical Microbiology, Radboud University Nijmegen Medical Center 268, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
出版信息
Infect Immun. 2008 Mar;76(3):873-8. doi: 10.1128/IAI.00431-07. Epub 2007 Dec 3.
Abstract
摘要
相似文献
1
Cross-species immunity in malaria vaccine development: two, three, or even four for the price of one?
Infect Immun. 2008 Mar;76(3):873-8. doi: 10.1128/IAI.00431-07. Epub 2007 Dec 3.
2
The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development.
Int J Parasitol. 2012 Aug;42(9):859-70. doi: 10.1016/j.ijpara.2012.07.001. Epub 2012 Jul 28.
3
Immunogenicity and structural efficacy of P41 of Plasmodium sp. as potential cross-species blood-stage malaria vaccine.
Comput Biol Chem. 2021 Jun;92:107493. doi: 10.1016/j.compbiolchem.2021.107493. Epub 2021 Apr 24.
4
Chemical Attenuation in the Development of a Whole-Organism Malaria Vaccine.
Infect Immun. 2017 Jun 20;85(7). doi: 10.1128/IAI.00062-17. Print 2017 Jul.
5
Chimeric parasites as tools to study Plasmodium immunology and assess malaria vaccines.
Methods Mol Biol. 2013;923:465-79. doi: 10.1007/978-1-62703-026-7_32.
6
Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites.
J Infect Dis. 2009 Mar 15;199(6):899-903. doi: 10.1086/597121.
7
Engineering of Genetically Arrested Parasites (GAPs) For a Precision Malaria Vaccine.
Front Cell Infect Microbiol. 2017 May 31;7:198. doi: 10.3389/fcimb.2017.00198. eCollection 2017.
8
Dendritic Cell Responses and Function in Malaria.
Front Immunol. 2019 Mar 4;10:357. doi: 10.3389/fimmu.2019.00357. eCollection 2019.
9
Mosquito-based transmission blocking vaccines for interrupting Plasmodium development.
Microbes Infect. 2008 Jul;10(8):845-9. doi: 10.1016/j.micinf.2008.05.004. Epub 2008 May 22.
10
A case for whole-parasite malaria vaccines.
Int J Parasitol. 2007 Jun;37(7):705-12. doi: 10.1016/j.ijpara.2007.02.007. Epub 2007 Feb 28.
引用本文的文献
1
alleviates disease manifestations caused by ANKA in murine co-infection model of complicated malaria.
Front Cell Infect Microbiol. 2023 Jul 10;13:1226088. doi: 10.3389/fcimb.2023.1226088. eCollection 2023.
2
Cross-species reactivity of antibodies against Plasmodium vivax blood-stage antigens to Plasmodium knowlesi.
PLoS Negl Trop Dis. 2020 Jun 19;14(6):e0008323. doi: 10.1371/journal.pntd.0008323. eCollection 2020 Jun.
3
The Consequences of Mixed-Species Malaria Parasite Co-Infections in Mice and Mosquitoes for Disease Severity, Parasite Fitness, and Transmission Success.
Front Immunol. 2020 Jan 22;10:3072. doi: 10.3389/fimmu.2019.03072. eCollection 2019.
4
Cross-species analysis of apical asparagine-rich protein of Plasmodium vivax and Plasmodium knowlesi.
Sci Rep. 2018 Apr 10;8(1):5781. doi: 10.1038/s41598-018-23728-1.
5
Immunological Cross-Reactivity between Malaria Vaccine Target Antigen P48/45 in Plasmodium vivax and P. falciparum and Cross-Boosting of Immune Responses.
PLoS One. 2016 Jul 20;11(7):e0158212. doi: 10.1371/journal.pone.0158212. eCollection 2016.
6
Studies on Immunogenicity and Antigenicity of Baculovirus-Expressed Binding Region of Plasmodium falciparum EBA-140 Merozoite Ligand.
Arch Immunol Ther Exp (Warsz). 2016 Apr;64(2):149-56. doi: 10.1007/s00005-015-0367-5. Epub 2015 Oct 6.
7
In vivo CD8+ T cell dynamics in the liver of Plasmodium yoelii immunized and infected mice.
PLoS One. 2013 Aug 14;8(8):e70842. doi: 10.1371/journal.pone.0070842. eCollection 2013.
8
NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections.
J Infect Dis. 2013 Feb 15;207(4):656-60. doi: 10.1093/infdis/jis725. Epub 2012 Nov 27.
9
Partnering parasites: evidence of synergism between heavy Schistosoma haematobium and Plasmodium species infections in Kenyan children.
PLoS Negl Trop Dis. 2012;6(7):e1723. doi: 10.1371/journal.pntd.0001723. Epub 2012 Jul 24.
10
Incidence of malaria in the interior division of sabah, malaysian borneo, based on nested PCR.
J Parasitol Res. 2011;2011:104284. doi: 10.1155/2011/104284. Epub 2011 Oct 13.
本文引用的文献
1
Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection.
Int J Parasitol. 2007 Nov;37(13):1511-9. doi: 10.1016/j.ijpara.2007.05.005. Epub 2007 May 21.
2
Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells.
Am J Pathol. 2007 Jul;171(1):107-15. doi: 10.2353/ajpath.2007.060792.
3
The risk of malarial infections and disease in Papua New Guinean children.
Am J Trop Med Hyg. 2007 Jun;76(6):997-1008.
4
Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection.
Infect Immun. 2007 Aug;75(8):3758-68. doi: 10.1128/IAI.00225-07. Epub 2007 May 21.
5
Plasmodium yoelii: experimental evidences for the conserved epitopes between mouse and human malaria parasite, Plasmodium falciparum.
Exp Parasitol. 2007 Jul;116(3):214-24. doi: 10.1016/j.exppara.2007.01.012. Epub 2007 Jan 27.
6
Cross-species Immunity in Malaria.
Parasitol Today. 1998 Apr;14(4):166. doi: 10.1016/s0169-4758(97)01189-7.
7
Vaccination against malaria with live parasites.
Expert Rev Vaccines. 2006 Aug;5(4):473-81. doi: 10.1586/14760584.5.4.473.
8
The phylogeny of rodent malaria parasites: simultaneous analysis across three genomes.
Infect Genet Evol. 2007 Jan;7(1):74-83. doi: 10.1016/j.meegid.2006.04.005. Epub 2006 Jun 9.
9
10
Pre-erythrocytic malaria vaccines: towards greater efficacy.
Nat Rev Immunol. 2006 Jan;6(1):21-32. doi: 10.1038/nri1746.
Zotero 插件